FindTrial
Sign In

An observational cohort study on predicting pathological acid reflux based on multidimensional testing for gastroesophageal reflux disease

An observational cohort study on predicting pathological acid reflux based on multidimensional testing for gastroesophageal reflux disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124800
Enrollment
Unknown
Registered
2026-05-18
Start date
2026-05-18
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal reflux disease

Interventions

Gastroesophageal reflux disease observation group:None

Sponsors

PLA Rocket Force Characteristic Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18–80 years; 2. Undergoing multidimensional GERD assessment due to gastroesophageal reflux-related symptoms, with at least gastroscopy, esophageal high resolution manometry, and reflux monitoring completed (acid-suppressive medication must be withdrawn for at least 7 days prior to testing).

Exclusion criteria

Exclusion criteria: 1. Diagnosed with achalasia; 2. With a history of upper gastrointestinal surgery.

Design outcomes

Primary

MeasureTime frame
Reflux esophagitis ;Hiatal hernia;Gastroesophageal laxity;Flap valve morphology;Total percentage of acid exposure time;Hiatal hernia;The hiatal long diameter;Overall acid-suppressive effect;GerdQ score;RSI score;—

Secondary

MeasureTime frame
Esophageal ulcer;Esophageal stricture ;Gastroesophageal flap valve;Hiatal hernia ;LES resting pressure;GERD-QOL score;—

Countries

China

Contacts

Public ContactDong Chen

PLA Rocket Force Characteristic Medical Center

739353406@qq.com+86 10 6634 3452

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026